ATE149524T1 - Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung - Google Patents

Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung

Info

Publication number
ATE149524T1
ATE149524T1 AT91111815T AT91111815T ATE149524T1 AT E149524 T1 ATE149524 T1 AT E149524T1 AT 91111815 T AT91111815 T AT 91111815T AT 91111815 T AT91111815 T AT 91111815T AT E149524 T1 ATE149524 T1 AT E149524T1
Authority
AT
Austria
Prior art keywords
human
human endothelin
vasocontracting
peptide
dna encoding
Prior art date
Application number
AT91111815T
Other languages
English (en)
Inventor
Haruo Onda
Shoichi Ohkubo
Takuo Kosaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE149524T1 publication Critical patent/ATE149524T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91111815T 1990-07-18 1991-07-16 Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung ATE149524T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18796090 1990-07-18
JP145191 1991-01-10
JP3143127A JP2999579B2 (ja) 1990-07-18 1991-06-14 Ｄｎａおよびその用途

Publications (1)

Publication Number Publication Date
ATE149524T1 true ATE149524T1 (de) 1997-03-15

Family

ID=27274926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91111815T ATE149524T1 (de) 1990-07-18 1991-07-16 Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung

Country Status (6)

Country Link
US (2) US6365725B1 (de)
EP (1) EP0468337B1 (de)
JP (1) JP2999579B2 (de)
AT (1) ATE149524T1 (de)
CA (1) CA2046754A1 (de)
DE (1) DE69124857T2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271286A (ja) * 1990-10-19 1993-10-19 General Hospital Corp エンドテリン前駆体、その遺伝子および受容体
US5756295A (en) * 1994-12-05 1998-05-26 Takeda Chemical Industries, Ltd. DNA primer and a method for screening DNAS
US6410802B1 (en) 1999-04-01 2002-06-25 Esperion Therapeutics, Inc. Methods for synthesizing ether compounds and intermediates therefor
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
JP2004531459A (ja) 2000-10-11 2004-10-14 エスペリオン セラピューティクス，インコーポレイテッド コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
CN1894195A (zh) 2000-10-11 2007-01-10 埃斯佩里安医疗公司 用于控制胆固醇以及相关用途的醚化合物以及组合物
CN101426763A (zh) 2000-10-11 2009-05-06 埃斯佩里安医疗公司 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
JP2005522504A (ja) * 2002-04-10 2005-07-28 エスペリオン セラピューティクス，インコーポレイテッド パントラクトンおよびパントテン酸誘導体を含むアシル補酵素−ａのミミック、その組成物、ならびにコレステロール管理の方法および関連の使用
US20050101565A1 (en) * 2002-07-03 2005-05-12 Esperion Therapeutics, Inc. Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders
ES2625429T3 (es) * 2003-01-23 2017-07-19 Esperion Therapeutics Inc. Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes
ATE428411T1 (de) * 2003-11-07 2009-05-15 Jj Pharma Inc Hdl-verstärkende kombinationstherapie-komplexe
JP2007525408A (ja) 2003-12-24 2007-09-06 エスペリオン セラピューティクス，インコーポレイテッド コレステロール管理および関連使用のためのケトン化合物および組成物
US20060075861A1 (en) * 2004-10-07 2006-04-13 Flooding Daniel L Film cutter
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
US8410109B2 (en) * 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US20100027114A1 (en) * 2006-12-19 2010-02-04 Koninklijke Philips Electronics N.V. Lens structure and manufacturing method, and the manufacture of shaped polymer articles
PT2118074E (pt) * 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US8481084B2 (en) 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
KR20100056507A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ｐｒｏ－ｇｌｙ－ｔｈｒ－ｃｙｓ－ｇｌｕ－ｉｌｅ－ｃｙｓ－ａｌａ－ｔｙｒ－ａｌａ－ａｌａ－ｃｙｓ－ｔｈｒ－ｇｌｙ－ｃｙｓ의 용도
SI2346837T1 (sl) 2008-06-26 2015-05-29 Resverlogix Corporation Postopki pripravljanja kinazolinonskih derivatov
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
WO2011027257A2 (en) 2009-09-03 2011-03-10 Pfizer Vaccines Llc Pcsk9 vaccine
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． ブロモドメイン阻害剤としての新規複素環式化合物
WO2015123291A1 (en) 2014-02-11 2015-08-20 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Pcsk9 vaccine and methods of using the same
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3267989A4 (de) 2015-03-13 2018-11-07 Esperion Therapeutics, Inc. Feste dosierungskombinationen und formulierungen mit etc1002 und ezetimib sowie verfahren zur behandlung oder verringerung des risikos einer kardiovaskulären erkrankung
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
MX2021015936A (es) 2019-06-21 2022-04-26 Esperion Therapeutics Inc Metodos para preparar acido bempedoico y composiciones del mismo.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807474B2 (ja) 1987-11-02 1998-10-08 武田薬品工業株式会社 Ｄｎａおよびその用途
US5231166A (en) 1988-10-25 1993-07-27 Takeda Chemical Industries, Ltd. Endothelin

Also Published As

Publication number Publication date
DE69124857D1 (de) 1997-04-10
US6365725B1 (en) 2002-04-02
EP0468337B1 (de) 1997-03-05
JPH04281790A (ja) 1992-10-07
US5756344A (en) 1998-05-26
JP2999579B2 (ja) 2000-01-17
CA2046754A1 (en) 1992-01-19
EP0468337A1 (de) 1992-01-29
DE69124857T2 (de) 1997-07-24

Similar Documents

Publication Publication Date Title
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
IL87025A (en) Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences
EP0416578A3 (en) Protein, dna and use thereof
ATE138101T1 (de) Dna-fragment, das ein polypeptid mit nitrilhydrataseaktivität kodiert, dna-fragment enthaltende transformante und verfahren zur herstellung von amiden unter verwendung der transformante
EP2189475A3 (de) Fibroblasten wachstumsfaktor-ähnliche Polypeptide
DE68929134D1 (de) Endothelin-DNA und Verwendung davon
IL107642A0 (en) Progenitor b cell stimulating factor
CA2263889A1 (en) P-selectin ligand proteins
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
DE58906718D1 (de) Kunststeine, verfahren zur herstellung und verwendung derselben.
ES8502476A1 (es) Un procedimiento para obtener polipeptidos similares a la hormona del crecimiento de ganado bovino
DE69125769D1 (de) Nukleotidsequenz, die für ein Aussenmembran-Protein von Neisseria meningitidis kodiert und Verwendung dieses Proteins zur Herstellung von Impfstoffen
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
NZ237661A (en) Growth regulatory proteins (epithelins) their production and diagnostic and therapeutic uses
DE69022297D1 (de) DNS und ihre Verwendung.
CA2200563A1 (en) Calcium free subtilisin mutants
TR199802252T2 (xx) N�ral ve renal geli�menin uyar�lmas� i�in ret ligand� (RetL)
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
EP0218531A3 (de) Immunogenische Peptide von menschlichem Interleukin-1 und die entsprechenden Antipeptid-Antikörper
DE3485336D1 (de) Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung.
WO1995030001A3 (en) Novel p-selectin ligand protein
GB9100825D0 (en) Pasteurella haemolytica glycoprotease gene and the purified enzyme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties